InvestorsObserver
×
News Home

Should You Accumulate Neurobo Pharmaceuticals Inc (NRBO) Stock Tuesday Morning?

Tuesday, October 19, 2021 08:24 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Neurobo Pharmaceuticals Inc (NRBO) Stock Tuesday Morning?

Neurobo Pharmaceuticals Inc (NRBO) is down -1.56%% today.

Overall Score - 28
NRBO has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on NRBO!
NRBO stock closed at $1.92 and is down -$0.03 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. NRBO has a poor overall score of 28 meaning the stock holds a better value than just 28% of stocks at its current price. InvestorsObserver's overall ranking system is a comprehensive evaluation and considers both technical and fundamental factors when evaluating a stock. The overall score is a great starting point for investors that are beginning to evaluate a stock. NRBO gets a average Short-Term Technical score of 60 from InvestorsObserver's proprietary ranking system. This means that the stock's trading pattern over the last month have been neutral. Neurobo Pharmaceuticals Inc currently has the 140th highest Short-Term Technical score in the Biotechnology industry. The Short-Term Technical score evaluates a stock's trading pattern over the past month and is most useful to short-term stock and option traders. Neurobo Pharmaceuticals Inc's Overall and Short-Term Technical score paint a mixed picture for NRBO's recent trading patterns and forecasted price. Click Here To Get The Full Report on Neurobo Pharmaceuticals Inc (NRBO)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App